0.12% Chlorhexidine Gluconate · CHLORHEXIDINE GLUCONATE 1.2 mg/mL · Rinse · Oral · Major Pharmaceuticals
NDC 00904-7035-88 · 15 mL in 1 CUP, UNIT-DOSE · ANDA · View full market →
Just 2 companies supply this market — thin enough that a single exit would be felt immediately. One of its named manufacturing plants, Xttrium Laboratories, Inc., failed FDA inspectionwithin the last two years — the agency’s most serious outcome.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Cardinal Health 107, LLC | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Major Pharmaceuticals | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Aug 5, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Major Oral Rinse — NDC 00904-7035-88," retrieved September 3, 2026, https://drugdashboards.com/drug/00904703588.
Free to cite with attribution — see how the data is put together.